Loring Wolcott & Coolidge Fiduciary Advisors LLP Bristol Myers Squibb CO Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 20,198 shares of BMY stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,198
Previous 22,362
9.68%
Holding current value
$1.02 Million
Previous $1.21 Million
30.86%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,478Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.39 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$8.2 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.62 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.48 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.54 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $107B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...